Anticanceragent 175 (complex 1) is a near-infrared luminescent therapeutic compound. It induces ROS accumulation, mitochondrial damage, disruption of the Bax/Bcl-2 balance, and apoptosis (apoptosis) in HepG2 cell lines.
Formula:
C81H86F10IrN8O4P-
Target:
Apoptosis|||Reactive Oxygen Species
* VAT and and shipping costs not included. Errors and price changes excepted
